Plus Therapeutics Inc
PSTV
NSC
Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
0.50
USD
0.02
(4.87%)
Optionable: No Market Cap: 11 M 90-day average vol: 4,270,809
Previous close: 0.472 Open: 0.4578 Bid: 0.495 Ask: 0.495
52 week range
0.39 2.16
Last updated: Thursday 29th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 1.16 |
PE Ratio (TTM) | -0.50 |
Book Value per Share ($) | 0.42 |
5 Year PE Range-1.1 |
Returns
7 Day Return | 1.85% | |
1 Month Return | -50.50% | |
3 Month Return | -8.35% | |
1 Year Return | -73.67% | |
3 Year Return | -85.53% | |
5 Year Return | -99.73% | |
YTD Return | -52.86% |
Risk
Custom Beta One Year | 0.99 |
Custom Beta Three Years | 1.23 |
Beneish M Score | 0.00 |
Altman Z Score | -29.08 |
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 37.34 |
14 Day SMA ($) | 0.56 |
14 Day EMA ($) | 0.56 |
Money Flow Index | 39.35 |
Average True Range | 0.09 |
50 Day SMA ($) | 0.62 |
200 Day SMA ($) | 0.79 |
ADX | 46.89 |
MACD | -0.06 |
Growth
Free Cash Flow QoQ Growth | -37.62% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 26.32% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
News
Financials
PSTV Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 15 M | 12 M | 8 M | 12 M | 11 M | 6 M | 3 M | 7 M | 303000 | 0 |
| Cost of sales | 3 M | 2 M | 2 M | 2 M | 351000 | -2 M | -2 M | -680000 | -366000 | -395000 |
| Gross operating profit | 11 M | 9 M | 5 M | 8 M | 10 M | 6 M | 3 M | 7 M | 303000 | 0 |
| Selling Gen & administrative expense | 25 M | 25 M | 22 M | 12 M | 12 M | 11 M | 6 M | 5 M | 6 M | 7 M |
| Research & development expense | 14 M | 17 M | 15 M | 19 M | 16 M | 12 M | 6 M | 5 M | 3 M | 6 M |
| Operating income | -28 M | -33 M | -33 M | -23 M | -20 M | -19 M | -9 M | -4 M | -10 M | -12 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -610000 | 11 M | -197000 | 8 M | 233000 | -2 M | 2 M | 2 M | 2 M | -60000 |
| Pre-tax Income (EBT) | -32 M | -26 M | -37 M | -19 M | -22 M | -23 M | -9 M | -3 M | -8 M | -13 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -32 M | -26 M | -37 M | -19 M | -22 M | -23 M | -13 M | -11 M | -8 M | -13 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -32 M | -26 M | -37 M | -19 M | -22 M | -23 M | -13 M | -11 M | -8 M | -13 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -32 M | -26 M | -37 M | -19 M | -22 M | -23 M | -9 M | -3 M | -8 M | -13 M |
| Depreciation | 933000 | 2 M | 779000 | 1 M | 1 M | 2 M | 2 M | 896000 | 366000 | 395000 |
| Amortization | 0 | 0 | 0 | 0 | 545000 | 1 M | 1 M | 306000 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -28 M | -21 M | -32 M | -14 M | -18 M | -18 M | -5 M | -532000 | -7 M | -12 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -3927.51 | -2784.96 | -3427.64 | -999.73 | -640 | -411.5 | -86.98 | -8.27 | -1.86 | -1.11 |
| Diluted EPS total | -3927.51 | -2784.96 | -3427.64 | -999.73 | -640 | -411.5 | -86.98 | -8.27 | -1.86 | -1.11 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today